Happening Now: TTLC 2022 Worldwide Virtual Event
The 2022 IASLC Targeted Therapies of Lung Cancer (TTLC) virtual meeting opened on February 22 and will run through February 26, featuring both live stream interaction and on-demand content covering the latest practice-changing science in thoracic cancer. The TTLC 2022 program features novel research on emerging combination immunotherapy approaches and targets such as KRAS G12C, and HER2, as well as relevant presentations on approaches to control acquired resistance to targeted therapies; it also covers the state of development of antibody-drug conjugates. Check out the TTLC 2022 virtual program here.
WCLC 2022 Registration Open; Abstract Submissions Deadline Approaching
Registration is now open for the IASLC 2022 World Conference on Lung Cancer, August 6–9 in Vienna. After two virtual conferences, WCLC 2022 plans to return to a face-to-face meeting with virtual elements that will allow anyone from anywhere in the world to join the largest international gathering in the field of lung cancer and thoracic oncology. Early registration rates end May 4, 2022.
The Program Committee for the IASLC 2022 World Conference on Lung Cancer invites the submission of scientific abstracts. Abstracts must be submitted no later than March 16, 2022, at 23:59 PST. Abstract submission guidelines, the types of abstracts accepted, important dates, FAQs, and more information are available on the conference website.
